Cargando…
Corrigendum: A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir
Autores principales: | Fernandes Campos, Guilherme Rodrigues, Ward, Joseph, Chen, Shucheng, Bittar, Cintia, Vilela Rodrigues, João Paulo, Candolo Martinelli, Ana de Lourdes, Souza, Fernanda Fernandes, Leira Pereira, Leonardo Régis, Rahal, Paula, Harris, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515857/ https://www.ncbi.nlm.nih.gov/pubmed/33787486 http://dx.doi.org/10.1099/jgv.0.001582 |
Ejemplares similares
-
A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir
por: Fernandes Campos, Guilherme Rodrigues, et al.
Publicado: (2020) -
Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
por: Rodrigues, João Paulo Vilela, et al.
Publicado: (2022) -
Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014) -
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
Publicado: (2019) -
Corrigendum to aPDT for oral decontamination of hospitalized patients with COVID 19()
por: Morimoto, Susana, et al.
Publicado: (2022)